[English] 日本語
![](img/lk-miru.gif)
- PDB-1ter: SOLUTION STRUCTURE OF TERTIAPIN DETERMINED USING NUCLEAR MAGNETIC... -
+
Open data
-
Basic information
Entry | Database: PDB / ID: 1ter | ||||||
---|---|---|---|---|---|---|---|
Title | SOLUTION STRUCTURE OF TERTIAPIN DETERMINED USING NUCLEAR MAGNETIC RESONANCE AND DISTANCE GEOMETRY | ||||||
![]() | TERTIAPIN | ||||||
![]() | TOXIN | ||||||
Function / homology | Honey bee toxin / Honey bee toxin / toxin activity / calmodulin binding / extracellular region / Tertiapin![]() | ||||||
Biological species | ![]() ![]() | ||||||
Method | SOLUTION NMR | ||||||
![]() | Xu, X. / Nelson, J.W. | ||||||
![]() | ![]() Title: Solution structure of tertiapin determined using nuclear magnetic resonance and distance geometry. Authors: Xu, X. / Nelson, J.W. | ||||||
History |
|
-
Structure visualization
Structure viewer | Molecule: ![]() ![]() |
---|
-
Downloads & links
-
Download
PDBx/mmCIF format | ![]() | 135.1 KB | Display | ![]() |
---|---|---|---|---|
PDB format | ![]() | 100 KB | Display | ![]() |
PDBx/mmJSON format | ![]() | Tree view | ![]() | |
Others | ![]() |
-Validation report
Summary document | ![]() | 349.3 KB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 474.6 KB | Display | |
Data in XML | ![]() | 19.6 KB | Display | |
Data in CIF | ![]() | 29.9 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Similar structure data |
---|
-
Links
-
Assembly
Deposited unit | ![]()
| |||||||||
---|---|---|---|---|---|---|---|---|---|---|
1 |
| |||||||||
Atom site foot note | 1: LEU 2 - CYS 3 MODEL 1 OMEGA = 218.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 2: ILE 8 - ILE 9 MODEL 1 OMEGA = 142.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 3: PRO 11 - HIS 12 MODEL 1 OMEGA = 225.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 4: HIS 12 - MET 13 MODEL 1 OMEGA = 144.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 5: LYS 17 - CYS 18 MODEL 1 OMEGA = 134.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 6: GLY 19 - LYS 20 MODEL 1 OMEGA = 234.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 7: LYS 20 - LYS 21 MODEL 1 OMEGA = 228.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 8: ARG 7 - ILE 8 MODEL 2 OMEGA = 213.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 9: PRO 11 - HIS 12 MODEL 2 OMEGA = 220.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 10: HIS 12 - MET 13 MODEL 2 OMEGA = 149.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 11: LYS 17 - CYS 18 MODEL 2 OMEGA = 131.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 12: GLY 19 - LYS 20 MODEL 2 OMEGA = 235.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 13: LYS 20 - LYS 21 MODEL 2 OMEGA = 231.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 14: LEU 2 - CYS 3 MODEL 3 OMEGA = 221.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 15: ASN 6 - ARG 7 MODEL 3 OMEGA = 148.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 16: ILE 9 - ILE 10 MODEL 3 OMEGA = 214.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 17: PRO 11 - HIS 12 MODEL 3 OMEGA = 227.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 18: HIS 12 - MET 13 MODEL 3 OMEGA = 147.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 19: LYS 17 - CYS 18 MODEL 3 OMEGA = 140.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 20: GLY 19 - LYS 20 MODEL 3 OMEGA = 222.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 21: LEU 2 - CYS 3 MODEL 4 OMEGA = 227.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 22: ASN 6 - ARG 7 MODEL 4 OMEGA = 145.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 23: ILE 8 - ILE 9 MODEL 4 OMEGA = 146.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 24: PRO 11 - HIS 12 MODEL 4 OMEGA = 225.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 25: HIS 12 - MET 13 MODEL 4 OMEGA = 141.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 26: LYS 17 - CYS 18 MODEL 4 OMEGA = 138.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 27: GLY 19 - LYS 20 MODEL 4 OMEGA = 237.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 28: LYS 20 - LYS 21 MODEL 4 OMEGA = 228.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 29: LEU 2 - CYS 3 MODEL 5 OMEGA = 215.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 30: ILE 8 - ILE 9 MODEL 5 OMEGA = 147.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 31: PRO 11 - HIS 12 MODEL 5 OMEGA = 234.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 32: CYS 14 - TRP 15 MODEL 5 OMEGA = 140.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 33: LYS 17 - CYS 18 MODEL 5 OMEGA = 141.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 34: GLY 19 - LYS 20 MODEL 5 OMEGA = 220.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 35: LYS 20 - LYS 21 MODEL 5 OMEGA = 148.49 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 36: LEU 2 - CYS 3 MODEL 6 OMEGA = 210.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 37: ASN 6 - ARG 7 MODEL 6 OMEGA = 146.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 38: ILE 8 - ILE 9 MODEL 6 OMEGA = 145.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 39: PRO 11 - HIS 12 MODEL 6 OMEGA = 234.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 40: HIS 12 - MET 13 MODEL 6 OMEGA = 145.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 41: LYS 17 - CYS 18 MODEL 6 OMEGA = 137.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 42: GLY 19 - LYS 20 MODEL 6 OMEGA = 236.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 43: LYS 20 - LYS 21 MODEL 6 OMEGA = 222.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 44: LEU 2 - CYS 3 MODEL 7 OMEGA = 214.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 45: ILE 8 - ILE 9 MODEL 7 OMEGA = 144.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 46: ILE 9 - ILE 10 MODEL 7 OMEGA = 211.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 47: PRO 11 - HIS 12 MODEL 7 OMEGA = 234.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 48: LYS 17 - CYS 18 MODEL 7 OMEGA = 130.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 49: GLY 19 - LYS 20 MODEL 7 OMEGA = 233.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 50: LYS 20 - LYS 21 MODEL 7 OMEGA = 240.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 51: LEU 2 - CYS 3 MODEL 8 OMEGA = 221.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 52: ASN 6 - ARG 7 MODEL 8 OMEGA = 147.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 53: ILE 8 - ILE 9 MODEL 8 OMEGA = 148.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 54: ILE 9 - ILE 10 MODEL 8 OMEGA = 217.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 55: PRO 11 - HIS 12 MODEL 8 OMEGA = 227.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 56: HIS 12 - MET 13 MODEL 8 OMEGA = 146.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 57: LYS 17 - CYS 18 MODEL 8 OMEGA = 141.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 58: GLY 19 - LYS 20 MODEL 8 OMEGA = 223.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 59: LYS 20 - LYS 21 MODEL 8 OMEGA = 148.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 60: LEU 2 - CYS 3 MODEL 9 OMEGA = 220.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 61: ILE 8 - ILE 9 MODEL 9 OMEGA = 143.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 62: ILE 9 - ILE 10 MODEL 9 OMEGA = 210.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 63: PRO 11 - HIS 12 MODEL 9 OMEGA = 233.09 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 64: LYS 17 - CYS 18 MODEL 9 OMEGA = 146.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 65: GLY 19 - LYS 20 MODEL 9 OMEGA = 240.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 66: LYS 20 - LYS 21 MODEL 9 OMEGA = 224.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 67: ARG 7 - ILE 8 MODEL 10 OMEGA = 213.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 68: ILE 9 - ILE 10 MODEL 10 OMEGA = 212.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 69: PRO 11 - HIS 12 MODEL 10 OMEGA = 229.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 70: HIS 12 - MET 13 MODEL 10 OMEGA = 142.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 71: LYS 17 - CYS 18 MODEL 10 OMEGA = 124.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 72: GLY 19 - LYS 20 MODEL 10 OMEGA = 232.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 73: LYS 20 - LYS 21 MODEL 10 OMEGA = 234.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 74: LEU 2 - CYS 3 MODEL 11 OMEGA = 222.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 75: CYS 3 - ASN 4 MODEL 11 OMEGA = 141.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 76: ASN 4 - CYS 5 MODEL 11 OMEGA = 148.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 77: ASN 6 - ARG 7 MODEL 11 OMEGA = 144.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 78: ILE 10 - PRO 11 MODEL 11 OMEGA = 147.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 79: PRO 11 - HIS 12 MODEL 11 OMEGA = 225.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 80: HIS 12 - MET 13 MODEL 11 OMEGA = 143.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 81: LYS 17 - CYS 18 MODEL 11 OMEGA = 136.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 82: GLY 19 - LYS 20 MODEL 11 OMEGA = 235.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 83: LYS 20 - LYS 21 MODEL 11 OMEGA = 231.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 84: LEU 2 - CYS 3 MODEL 12 OMEGA = 210.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 85: ASN 6 - ARG 7 MODEL 12 OMEGA = 146.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 86: ILE 9 - ILE 10 MODEL 12 OMEGA = 210.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 87: PRO 11 - HIS 12 MODEL 12 OMEGA = 234.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 88: HIS 12 - MET 13 MODEL 12 OMEGA = 136.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 89: LYS 17 - CYS 18 MODEL 12 OMEGA = 142.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 90: GLY 19 - LYS 20 MODEL 12 OMEGA = 239.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 91: LYS 20 - LYS 21 MODEL 12 OMEGA = 223.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 92: ASN 6 - ARG 7 MODEL 13 OMEGA = 141.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 93: ILE 9 - ILE 10 MODEL 13 OMEGA = 212.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 94: PRO 11 - HIS 12 MODEL 13 OMEGA = 236.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 95: HIS 12 - MET 13 MODEL 13 OMEGA = 132.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 96: LYS 17 - CYS 18 MODEL 13 OMEGA = 132.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 97: GLY 19 - LYS 20 MODEL 13 OMEGA = 235.01 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 98: LYS 20 - LYS 21 MODEL 13 OMEGA = 228.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 99: ARG 7 - ILE 8 MODEL 14 OMEGA = 211.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 100: ILE 10 - PRO 11 MODEL 14 OMEGA = 148.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 101: PRO 11 - HIS 12 MODEL 14 OMEGA = 227.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 102: HIS 12 - MET 13 MODEL 14 OMEGA = 140.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 103: LYS 17 - CYS 18 MODEL 14 OMEGA = 131.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 104: CYS 18 - GLY 19 MODEL 14 OMEGA = 149.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 105: GLY 19 - LYS 20 MODEL 14 OMEGA = 242.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 106: LYS 20 - LYS 21 MODEL 14 OMEGA = 227.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 107: ILE 8 - ILE 9 MODEL 15 OMEGA = 144.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 108: ILE 9 - ILE 10 MODEL 15 OMEGA = 210.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 109: PRO 11 - HIS 12 MODEL 15 OMEGA = 229.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 110: HIS 12 - MET 13 MODEL 15 OMEGA = 146.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 111: LYS 17 - CYS 18 MODEL 15 OMEGA = 143.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 112: GLY 19 - LYS 20 MODEL 15 OMEGA = 240.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 113: LYS 20 - LYS 21 MODEL 15 OMEGA = 221.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 114: ILE 9 - ILE 10 MODEL 16 OMEGA = 222.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 115: PRO 11 - HIS 12 MODEL 16 OMEGA = 214.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 116: LYS 20 - LYS 21 MODEL 16 OMEGA = 149.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 117: ILE 9 - ILE 10 MODEL 17 OMEGA = 211.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 118: PRO 11 - HIS 12 MODEL 17 OMEGA = 214.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 119: LYS 17 - CYS 18 MODEL 17 OMEGA = 147.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 120: LYS 20 - LYS 21 MODEL 17 OMEGA = 148.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 121: ILE 9 - ILE 10 MODEL 18 OMEGA = 219.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 122: PRO 11 - HIS 12 MODEL 18 OMEGA = 225.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 123: LYS 17 - CYS 18 MODEL 18 OMEGA = 147.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 124: LYS 20 - LYS 21 MODEL 18 OMEGA = 142.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 125: LEU 2 - CYS 3 MODEL 19 OMEGA = 217.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 126: ILE 9 - ILE 10 MODEL 19 OMEGA = 221.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 127: PRO 11 - HIS 12 MODEL 19 OMEGA = 220.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 128: LYS 17 - CYS 18 MODEL 19 OMEGA = 144.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 129: LYS 20 - LYS 21 MODEL 19 OMEGA = 216.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 130: LEU 2 - CYS 3 MODEL 20 OMEGA = 211.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 131: PRO 11 - HIS 12 MODEL 20 OMEGA = 223.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 132: LYS 17 - CYS 18 MODEL 20 OMEGA = 141.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 133: LYS 20 - LYS 21 MODEL 20 OMEGA = 145.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 134: ASN 4 - CYS 5 MODEL 21 OMEGA = 147.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 135: ILE 9 - ILE 10 MODEL 21 OMEGA = 214.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 136: PRO 11 - HIS 12 MODEL 21 OMEGA = 220.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 137: LYS 17 - CYS 18 MODEL 21 OMEGA = 141.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION 138: LYS 20 - LYS 21 MODEL 21 OMEGA = 135.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION | |||||||||
NMR ensembles |
|
-
Components
#1: Protein/peptide | Mass: 2464.141 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() |
---|
-Experimental details
-Experiment
Experiment | Method: SOLUTION NMR |
---|
-
Sample preparation
Crystal grow | *PLUS Method: other / Details: NMR |
---|
-
Processing
NMR ensemble | Conformers submitted total number: 21 |
---|